| Title: | Optimizing midlife metabolic syndrome thresholds for dementia: a prospective study of two UK population-based cohorts |
| Journal: | Alzheimer's Research & Therapy |
| Published: | 23 Apr 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40269987/ |
| DOI: | https://doi.org/10.1186/s13195-025-01732-8 |
| URL: | https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-025-01732-8 |
Publication 15773
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundThe concept of metabolic syndrome (MetS) was developed to identify individuals at higher risk of type 2 diabetes and cardiovascular disease, but its relevance for dementia remains unclear. We examined MetS in midlife for association with late-onset dementia, focusing on the thresholds of MetS components that carry risk for dementia.MethodsMetS components (waist circumference, blood pressure, triglycerides, HDL-C, and fasting glucose) were measured on 6,137 white participants < 60 years from the Whitehall II (WII) cohort study. A changepoint method in time-to-event analyses was used to identify optimal thresholds, and those exhibiting better performance for dementia were retained to develop a revised MetS definition. Results were validated on 171,886 participants in the UK Biobank (UKB) study.ResultsOver a median follow-up of 22.6 years in WII and 13.8 years in UKB, 522 and 418 late-onset dementia cases were recorded, respectively. Optimized thresholds for triglycerides and fasting glucose performed better than original MetS thresholds in WII, and were used to develop a revised MetS definition. The MetS scale had a linear association with dementia, and 1-component increment (range 0 to 5) was associated with higher dementia risk using the revised MetS definition (HR, 95% CI: 1.11, 1.03-1.19) but not the original MetS definition (HR, 95% CI: 1.06, 0.98-1.14) in WII. In UKB, the revised MetS definition exhibited better performance for dementia risk than the original definition (p for HR comparison < 0.01).ConclusionsMetS in midlife is potentially an important target for dementia prevention. However, the thresholds for triglycerides and glucose that carry risk need to be tailored specifically for dementia.</p>
13 Keywords
- Aged
- Blood Glucose
- Cohort Studies
- Dementia
- Female
- Humans
- Male
- Metabolic Syndrome
- Middle Aged
- Prospective Studies
- Risk Factors
- Triglycerides
- United Kingdom
6 Authors
- Sam Vidil
- Archana Singh-Manoux
- Benjamin Landré
- Aurore Fayosse
- Séverine Sabia
- Marcos D. Machado-Fragua
1 Application
| Application ID | Title |
|---|---|
| 96856 | Determinants of functional decline, multimorbidity and neurodegenerative diseases: a triangulation approach |
Enabling scientific discoveries that improve human health